Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Amy Molan
Observed names:
A Molan,
Amy M. Molan
Institution:
Medtronic (United States)
Observed institutions:
University of Minnesota,
University of Leeds,
Mayo Clinic,
Institute of Cancer Research,
Cancer Research UK,
Medtronic (United States)
show all 6
OpenAlex ID:
A5064940978
Leadless pacemakers reduce risk of device-related infection: Review of the potential mechanisms
2020
·
Mikhael F. El-Chami
, Matt Bonner
, et al.
·
Heart Rhythm
·
158
PDF
Antitachycardia pacing success in implantable cardioverter-defibrillators by patient, device, and programming characteristics
2022
·
Laurence D. Sterns
, Angelo Auricchio
, et al.
·
Heart Rhythm
·
28
Performance evaluation of implantable cardioverter-defibrillators with SmartShock technology in patients with inherited arrhythmogenic diseases
2022
·
Angelo Auricchio
, Laurence D. Sterns
, et al.
·
International Journal of Cardiology
·
8
64. Generation of Tumor Cells Resistant to Oncolysis Is Mediated Through Virus Induced APOBEC Expression
2016
·
Karishma Rajani
, Kevin G. Shim
, et al.
·
Molecular Therapy
·
1
PDF
Abstract B138: Cancer immunotherapy with APOBEC3B-induced heteroclitic library tumor cell vaccines and immune checkpoint blockade
2019
·
Richard Vile
, Laura Evgin
, et al.
·
Cancer Immunology Research
Abstract A133: APOBEC3 confers resistance to oncolytic VSV therapy
2019
·
Amanda L. Huff
, Phonphimon Wongthida
, et al.
·
Cancer Immunology Research
Regulation of APOBEC3B and the Restriction of HIV-1 in Myeloid Cells
2018
·
Amy Molan
·
University of Minnesota Digital Conservancy (University of Minnesota)
PDF
Abstract P4-08-02: APOBEC3B upregulation by the PKC-NFκB pathway in breast cancer
2016
·
J McCann
, B Leonard
, et al.
·
Cancer Research
Show more works
View as search
Works count:
8
Citation count:
195
H-index:
3
I10-index:
2
Year
Topic
Type
